SomnoMed Ltd
RJV
Company Profile
Business description
SomnoMed Ltd is a public company providing treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. Its products include SomnoDent, SomMorning Repositioner, SomnoBrux and SomTab. It produces and sells devices for the oral treatment of sleep-related disorders mainly in Asia Pacific, North America and Europe, with maximum revenue generated from Europe.
Contact
20 Clarke Street
Level 3
Crows Nest
SydneyNSW2065
AUST: +61 294670400
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
Employees
22
Stocks News & Analysis
stocks
Anthropic and OpenAI face commodification threats. Here’s what to watch for
Frontier AI labs face a three-pronged set of challenges.
stocks
Berkshire Hathaway: Abel pushes into new territory with Bending Spoons investment
We think it is a sign that the firm is finally moving out of its comfort zone to find places to put capital to work.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,922.80 | 52.90 | -0.59% |
| CAC 40 | 7,868.05 | 88.65 | -1.11% |
| DAX 40 | 25,319.77 | 302.84 | -1.18% |
| Dow JONES (US) | 51,966.03 | 36.38 | -0.07% |
| FTSE 100 | 10,764.69 | 117.21 | -1.08% |
| HKSE | 24,186.83 | 124.11 | 0.52% |
| NASDAQ | 26,430.89 | 290.85 | 1.11% |
| Nikkei 225 | 64,916.70 | 407.59 | -0.62% |
| NZX 50 Index | 13,671.95 | 19.88 | 0.15% |
| S&P 500 | 7,690.73 | 31.29 | 0.41% |
| S&P/ASX 200 | 8,790.80 | 54.90 | -0.62% |
| SSE Composite Index | 3,716.28 | 8.81 | 0.24% |